| Ticker: | AEMD |
| Current Price: | $5.05 |
| % Daily Change: | -2.70% |
| Volume (1,000s): | 45.57 |
| Average Volume (1,000s): | 656.71 |
| Market Cap (M): | $2.66 |
| 1/2/2024 Price: | $2.17 |
| Change Since Inception: | 133.26% |
9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
United States
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.